Medication info

Posalin Tablets 5 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Hwanin Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle, Box - 28 tablets/box [7 tablets/Alu-Alu x 4]
Approval status
Active

MFDS item code 202201074 · Approved 2022.03.15

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug therapy, when administered in combination with metformin, the recommended initial dose of this drug is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Hwanin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication helps patients with type 2 diabetes effectively control their blood sugar. It is used as an adjunct to diet and exercise, and can be administered alone or in combination with other medications. It is particularly useful for patients with type 2 diabetes who have cardiovascular diseases or risk factors. This medication can improve blood sugar levels, aiding in diabetes management, and may contribute to reducing the risk of cardiovascular events. Please refer to professional information for detailed descriptions. This medication is effectively used in the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug therapy, when administered in combination with metformin, the recommended initial dose of this drug is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who are allergic to the active ingredient or excipients. It should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Caution should be exercised in patients with reduced fluid volume or impaired kidney function, as blood pressure may drop or kidney function may rapidly change. Elderly patients or those taking diuretics may require additional precautions due to higher risks of hypotension and decreased blood volume. Blood sugar control effects may vary based on kidney function, and this medication is not recommended for patients with severely impaired renal function. The most commonly occurring side effect in clinical trials is genital infections, which may occur more frequently in women or patients with a history of infections. Hypoglycemia may occur more frequently when used with insulin or sulfonylureas, potentially necessitating dose adjustments. Symptoms of dehydration or hypotension may occur due to reduced fluid volume, so symptoms should be monitored closely. Serious metabolic disturbances such as diabetic ketoacidosis may arise, thus immediate consultation with medical personnel is necessary if symptoms such as vomiting, abdominal pain, or breathing difficulties occur. Risk of urinary tract infections, such as pyelonephritis, may also increase, so prompt treatment is required if relevant symptoms arise. This medication may temporarily worsen kidney function, necessitating regular kidney function tests. Rare but serious infections such as Fournier's gangrene can occur, so immediate medical attention is necessary if pain, swelling, or fever around the genital area arises. It is advisable not to use this medication during pregnancy, and it should also be avoided in breastfeeding cases. Elderly patients require closer monitoring due to higher risks of decreased kidney function and fluid volume reduction. Dose adjustments may be necessary when taking with insulin, sulfonylureas, or diuretics to mitigate the risks of hypotension or hypoglycemia. There is no specific antidote in cases of overdose, so appropriate treatment based on symptoms is essential. During the medication period, regular blood sugar monitoring should be conducted, with particular attention to hypoglycemia symptoms. The safety and efficacy of this medication in pediatric patients have yet to be established, so its use is discouraged. Finally, this medication should be kept out of the reach of children and stored in its original container to maintain quality.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, nasopharyngitis, upper respiratory tract infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, hunger, vaginal discharge, itching, urticaria, cold sweat, joint pain, musculoskeletal pain, limb pain, muscular weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle, Box - 28 tablets/box [7 tablets/Alu-Alu x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.